In a setback to Bharat Biotech's COVID-19 vaccine Covaxin, the US Food and Drug Administration has "recommended" Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence...
from NDTV News - Topstories https://ift.tt/3gd4P7t
https://ift.tt/eA8V8J
Friday, June 11, 2021
Home »
» US Delays Use Of India-Made COVID-19 Vaccine Covaxin. What It Recommended
0 comments:
Post a Comment